Hypera Rejects Merger with EMS, Shares Plunge Over 7% on B3

Hypera’s stock fell over 7% shortly after the market opened on October 24, reacting to the company’s rejection of a merger proposal from EMS. The pharmaceutical company’s shares ranked among the largest losers on the Ibovespa index. This decline followed Hypera’s announcement that it had rejected an unsolicited merger offer from EMS. In a market […]

Leave a Reply

Your email address will not be published. Required fields are marked *